Lauren Merendino is Chief Commercial Officer at Myovant Sciences Ltd.

In the past Ms. Merendino held the position of Vice President-Neurological Rare Diseases at Genentech, Inc.

She received an undergraduate degree from The Pennsylvania State University and an MBA from New York University.